SBI Securities »

Nektar Therapeutics shares owned by SBI Securities

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by SBI Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.9k 156 56.90
2025-06-30 $4.1k 160 25.84

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Tesla Motors (TSLA)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
Vanguard Total World Stock ETF Etf (VT)
Amazon (AMZN)
Vanguard High Dividend Yield ETF Etf (VYM)
Alphabet Inc Class A cs (GOOGL)
SPDR Portfolio S&P500 HighDividend ETF Etf (SPYD)
Facebook Inc cl a (META)
Direxion Daily Semi Bull 3X Etf (SOXL)

View all positions for SBI Securities

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics